Protagenic Therapeutics Inc (PTIX) concluded trading on Wednesday at a closing price of $0.23, with 13.44 million shares of worth about $3.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -63.82% during that period and on April 03, 2025 the price saw a loss of about -9.20%. Currently the company’s common shares owned by public are about 7.24M shares, out of which, 6.52M shares are available for trading.
Stock saw a price change of -13.69% in past 5 days and over the past one month there was a price change of -38.33%. Year-to-date (YTD), PTIX shares are showing a performance of -53.67% which decreased to -87.53% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.18 but also hit the highest price of $1.87 during that period. The average intraday trading volume for Protagenic Therapeutics Inc shares is 2.08 million. The stock is currently trading -14.52% below its 20-day simple moving average (SMA20), while that difference is down -24.74% for SMA50 and it goes to -59.96% lower than SMA200.
Protagenic Therapeutics Inc (NASDAQ: PTIX) currently have 7.24M outstanding shares and institutions hold larger chunk of about 5.18% of that.
The stock has a current market capitalization of $1.71M. It has posted earnings per share of -$1.13 in the same period. It has Quick Ratio of 2.00 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PTIX, volatility over the week remained 18.73% while standing at 15.35% over the month.
